With recognized core competencies in solution design, material know-how and product industrialization, we are a strategic engineering partner for innovative systems in global markets such as Healthcare, Mobility, Connectivity, General Industry and Food & Beverage. Read more about us.
Datwyler strengthens its market position and drives growth by commencing serial supply of premium components for GLP-1 therapies, reflecting its strategic investments and early-stage development partnerships within the rapidly expanding injectable drug market.
The 67th Annual General Meeting of Dätwyler Holding Inc. was held in Altdorf on Tuesday, 18 March 2025.
Datwyler is a new member of the Circular Rubber Platform, through which it is actively committing to a more sustainable circular economy in the elastomer industry.
Datwyler has been partnering with the non-governmental organization Planet Water for several years to improve access to clean drinking water in Maharashtra, India.
Datwyler slightly increased its EBIT margin in 2024 despite weak markets and a slight decline in revenue. The transformation program «ForwardNow» will accelerate the planned profitable growth.
I am proud to work for a company that contributes so much to world health. At our core values, we continue to bring new innovation and offer the highest quality products to support our Pharma partners.
Douglas Stout
Head of Sales, North America
We aim to be a pro-active organisation and use innovative processes while being compliant with relevant regulations and standards. We embed quality principles in our complete value chain. We encourage cross-functional collaboration and engage everyone to achieve sustainable solutions for our customers.
Billions of syringes worldwide contain Datwyler components. We are global number two for Sealing Solutions for Parenteral Medicines & Medical Devices.
We are dedicated to continuous improvement in all we do. Our quality management system is supported by digitalisation thus enabling analysis, exchange of knowledge, and standardisation. We use a risk-based approach and our expertise to meet the changing needs of our customers and other stakeholders and to shape future oriented processes.
After more than 20 years at the company, I am proud to say I still feel very motivated to continue my work and provide our customers with better solutions for the future.
Agna Francis
Head of Material Development Healthcare
Pre-Filled Syringes West Coast
Booth #G098
Booth #N5F06
